SIRT1 in Secretory Organ Cancer

por Frazzi, Raffaele
Publicado 2018

BIRC3 and BIRC5: multi‐faceted inhibitors in cancer

por Frazzi, Raffaele
Publicado 2021

The Multiple Mechanisms of Cell Death Triggered by Resveratrol in Lymphoma and Leukemia

por Frazzi, Raffaele, Tigano, Marco
Publicado 2014

Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells

por Frazzi, Raffaele, Guardi, Manuela
Publicado 2017

Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases

por Lançon, Allan, Frazzi, Raffaele, Latruffe, Norbert
Publicado 2016

Methylation Heterogeneity and Gene Expression of SPG20 in Solid Tumors

por Cusenza, Vincenza Ylenia, Braglia, Luca, Frazzi, Raffaele
Publicado 2022

The Significance of Microenvironmental and Circulating Lactate in Breast Cancer

por Frisardi, Vincenza, Canovi, Simone, Vaccaro, Salvatore, Frazzi, Raffaele
Publicado 2023

The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer

por Cusenza, Vincenza Ylenia, Tameni, Annalisa, Neri, Antonino, Frazzi, Raffaele
Publicado 2023

Copy Number Variation and Rearrangements Assessment in Cancer: Comparison of Droplet Digital PCR with the Current Approaches

por Cusenza, Vincenza Ylenia, Bisagni, Alessandra, Rinaldini, Monia, Cattani, Chiara, Frazzi, Raffaele
Publicado 2021

Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies

por Frazzi, Raffaele, Auffray, Charles, Ferrari, Angela, Filippini, Perla, Rutella, Sergio, Cesario, Alfredo
Publicado 2016

KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells

por Frazzi, Raffaele, Cusenza, Vincenza Ylenia, Pistoni, Mariaelena, Canovi, Laura, Cascione, Luciano, Bertoni, Francesco, Merli, Francesco
Publicado 2022